A Practical Roadmap for IND-Enabling Safety and Toxicology Studies, Upcoming Webinar Hosted by Xtalks

Preclinical toxicology studies should reliably assess the safety of new drug entities, thus building a multi-faceted understanding of compounds to lay the groundwork for clinical trials and regulatory approval.

Information
Retrieved on: 
Thursday, October 14, 2021 - 1:30pm
Organisation: 
Xtalks
Geotags: 
Content
Key Points: 
  • Preclinical toxicology studies should reliably assess the safety of new drug entities, thus building a multi-faceted understanding of compounds to lay the groundwork for clinical trials and regulatory approval.
  • In this webinar, our featured speaker will present a roadmap that seamlessly integrates the various preclinical studies, thus accelerating the initiation of clinical trials.
  • Register for this webinar to learn about the best way to plan for investigational new drug (IND)-enabling preclinical toxicology studies.
  • For more information, or to register for this event, visit A Practical Roadmap for IND-Enabling Safety and Toxicology Studies.


A Practical Roadmap for IND-Enabling Safety and Toxicology Studies, Upcoming Webinar Hosted by Xtalks

TORONTO, Oct. 14, 2021 /PRNewswire-PRWeb/ -- Well-designed and meticulously implemented preclinical toxicology studies are crucial for the success of any drug development program. Preclinical toxicology studies should reliably assess the safety of new drug entities, thus building a multi-faceted understanding of compounds to lay the groundwork for clinical trials and regulatory approval. At times, preclinical studies may lead to the attrition of compounds during preclinical development or the Good Laboratory Practices (GLP) toxicology phase; this helps save millions of dollars during the drug development program.

In this webinar, our featured speaker will present a roadmap that seamlessly integrates the various preclinical studies, thus accelerating the initiation of clinical trials. The roadmap covers various aspects of the preclinical journey, developing a tox-suitable formulation, running the dose range finding (DRF) to set the doses for GLP toxicology and the full scale of GLP tox studies.

Register for this webinar to learn about the best way to plan for investigational new drug (IND)-enabling preclinical toxicology studies.

Join Dr. Mohan Krishnappa, DVM, PhD, Head – Safety Assessment, Syngene International Ltd., for the live webinar on Tuesday, November 2, 2021 at 11am EDT (3pm GMT/UK).

For more information, or to register for this event, visit A Practical Roadmap for IND-Enabling Safety and Toxicology Studies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, arashid@xtalks.com

 

SOURCE Xtalks